G.NandalA.ParkJ
This is known as combination therapy
CagriSema's Advantages: First to Market: 6-12 month head start Leverages Wegovy Success: Built-in brand recognition Proven Semaglutide Component: Half the drug is already approved Strong Diabetes Data: Positions for dual indication No Dysesthesia: Cleaner safety profile in one key area Retatrutide's Advantages: Higher Efficacy: 28.7% vs 20.4% (8.3 points more) Superior BP Reduction: -14 mmHg vs likely similar to semaglutide Single Molecule: Potentially easier manufacturing Multiple Indications: OA, OSA, obesity, diabetes trials Novel Class: First triple agonist = strong IP protection The Verdict: Market Will Support Both These medications won't compete head-to-head
Pinnell SR, Yang H, Omar M, Riviere NM, DeBuys HV, Walker LC et al (2001) Topical L-ascorbic acid: percutaneous absorption studies
Prior weight loss drugs were unpleasant (rimonabant), ineffective (Contrave), or dangerous (methamphetamine, fen-phen, 2,4-DNP)
If we find that your hormone levels are lacking, we may suggest our program for HRT for weight loss in Kansas City to get your metabolism back on track
